175 related articles for article (PubMed ID: 19024344)
41. A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.
Bruhn O; Regenhard P; Michalek M; Paul S; Gelhaus C; Jung S; Thaller G; Podschun R; Leippe M; Grötzinger J; Kalm E
Biochem J; 2007 Oct; 407(2):267-76. PubMed ID: 17620056
[TBL] [Abstract][Full Text] [Related]
42. Release of anti-HIV mediators after administration of leukotriene B4 to humans.
Flamand L; Borgeat P; Lalonde R; Gosselin J
J Infect Dis; 2004 Jun; 189(11):2001-9. PubMed ID: 15143466
[TBL] [Abstract][Full Text] [Related]
43. [Activity of defensins from human neutrophils against Mycobacterium avium complex].
Ogata K; Koga T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 May; 31(5):587-92. PubMed ID: 8331844
[TBL] [Abstract][Full Text] [Related]
44. Intramolecular inhibition of human defensin HNP-1 by its propiece.
Valore EV; Martin E; Harwig SS; Ganz T
J Clin Invest; 1996 Apr; 97(7):1624-9. PubMed ID: 8601627
[TBL] [Abstract][Full Text] [Related]
45. Direct inactivation of viruses by human granulocyte defensins.
Daher KA; Selsted ME; Lehrer RI
J Virol; 1986 Dec; 60(3):1068-74. PubMed ID: 3023659
[TBL] [Abstract][Full Text] [Related]
46. Monocyte-chemotactic activity of defensins from human neutrophils.
Territo MC; Ganz T; Selsted ME; Lehrer R
J Clin Invest; 1989 Dec; 84(6):2017-20. PubMed ID: 2592571
[TBL] [Abstract][Full Text] [Related]
47. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
[TBL] [Abstract][Full Text] [Related]
48. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.
Peschel A; Jack RW; Otto M; Collins LV; Staubitz P; Nicholson G; Kalbacher H; Nieuwenhuizen WF; Jung G; Tarkowski A; van Kessel KP; van Strijp JA
J Exp Med; 2001 May; 193(9):1067-76. PubMed ID: 11342591
[TBL] [Abstract][Full Text] [Related]
49. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa.
Cunliffe RN; Kamal M; Rose FR; James PD; Mahida YR
J Clin Pathol; 2002 Apr; 55(4):298-304. PubMed ID: 11919217
[TBL] [Abstract][Full Text] [Related]
50. Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis.
Dietrich DE; Xiao X; Dawson DV; Bélanger M; Xie H; Progulske-Fox A; Brogden KA
Infect Immun; 2008 Dec; 76(12):5714-20. PubMed ID: 18852241
[TBL] [Abstract][Full Text] [Related]
51. alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.
Mackewicz CE; Yuan J; Tran P; Diaz L; Mack E; Selsted ME; Levy JA
AIDS; 2003 Sep; 17(14):F23-32. PubMed ID: 14502030
[TBL] [Abstract][Full Text] [Related]
52. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection.
Hazrati E; Galen B; Lu W; Wang W; Ouyang Y; Keller MJ; Lehrer RI; Herold BC
J Immunol; 2006 Dec; 177(12):8658-66. PubMed ID: 17142766
[TBL] [Abstract][Full Text] [Related]
53. Multifaceted immune functions of human defensins and underlying mechanisms.
Fruitwala S; El-Naccache DW; Chang TL
Semin Cell Dev Biol; 2019 Apr; 88():163-172. PubMed ID: 29501617
[TBL] [Abstract][Full Text] [Related]
54. Defensins. Natural peptide antibiotics of human neutrophils.
Ganz T; Selsted ME; Szklarek D; Harwig SS; Daher K; Bainton DF; Lehrer RI
J Clin Invest; 1985 Oct; 76(4):1427-35. PubMed ID: 2997278
[TBL] [Abstract][Full Text] [Related]
55. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91.
Presicce P; Giannelli S; Taddeo A; Villa ML; Della Bella S
J Leukoc Biol; 2009 Oct; 86(4):941-8. PubMed ID: 19477909
[TBL] [Abstract][Full Text] [Related]
56. Human neutrophil peptide-1 decreases during ageing in selected Mexican population.
Rivas-Santiago B; Castañeda-Delgado JE; de Haro-Acosta J; Torres-Juarez F; Frausto-Lujan I; Marin-Luevano P; González-Amaro R; Enciso-Moreno JA
Immunol Res; 2016 Apr; 64(2):445-54. PubMed ID: 26323500
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of anticancer activity of α-defensins purified from neutrophils trapped in leukoreduction filters.
Ferdowsi S; Pourfathollah AA; Amiri F; Rafiee MH; Aghaei A
Life Sci; 2019 May; 224():249-254. PubMed ID: 30935951
[TBL] [Abstract][Full Text] [Related]
58. Defensins and mucosal protection.
Mahida YR; Cunliffe RN
Novartis Found Symp; 2004; 263():71-7; discussion 77-84, 211-8. PubMed ID: 15669635
[TBL] [Abstract][Full Text] [Related]
59. [Characteristics of the main groups of human host-defensive peptides].
Lapis K
Orv Hetil; 2009 Jan; 150(3):109-19. PubMed ID: 19129146
[TBL] [Abstract][Full Text] [Related]
60. A newly discovered function of palatine tonsils in immune defence: the expression of defensins.
Weise JB; Meyer JE; Helmer H; Wittrock H; Maune S
Otolaryngol Pol; 2002; 56(4):409-13. PubMed ID: 12378798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
